中新报道有反馈｜市野医生等涉事产品被下架

Core Points - The article discusses the removal of products from brands such as "Shiye Doctor," "Canglaozu," and "Miaoajie" from e-commerce platforms following a report that exposed misleading claims about their effectiveness and origins [1][4] - The Zhengzhou Market Supervision Administration has taken administrative actions against the involved companies after the report highlighted deceptive marketing practices [1] - A specific product, "Shiye Doctor" pain relief patch, claimed to have rapid healing properties and was marketed as a Japanese patented product, but it was revealed to be a low-cost generic product produced locally [1] Group 1 - The brands "Shiye Doctor," "Canglaozu," and "Miaoajie" have been removed from e-commerce platforms as of September 20 [4] - The "Shiye Doctor" flagship store on Tmall plans to terminate operations by October 14, 2025 [4] - Related short video platforms have cleared the stores associated with "Shiye Doctor" and have banned advertising for these brands [4] Group 2 - The "Shiye Doctor" product claimed to provide "2-minute bone healing" and was marketed as developed by the "Tokyo Medical Research Institute," which is actually a newly registered entity in Hong Kong [1] - The product was produced at a cost of only 2 yuan per box, indicating significant markup in its retail price [1] - The brands involved utilized similar marketing strategies, leveraging terms like "ancestral" and "certified medical device" to gain consumer trust [1]